ARCHIVES

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 34 No. 07 | February 22, 2008

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

DOD funds $4.2 million gynecologic oncology research program at four institutions.

July 2, 2004

For Research Projects In Cancer Therapy

March 1, 1996

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983